Low Serum ZAG Levels Correlate With Determinants of the Metabolic Syndrome in Chinese Subjects.
Ontology highlight
ABSTRACT: Introduction: Zinc-α2-glycoprotein (ZAG) is a novel adipokine, which is involved in metabolic syndrome (MetS). This study aimed to investigate the relationship between serum ZAG and MetS in Chinese adults, who diagnosed according to the 2005 International Diabetes Federation (IDF) criteria. Methods: A group of 151 MetS patients, 84 patients with central obesity and 70 healthy controls were enrolled. General clinical information, serum samples were obtained from all subjects and serum ZAG levels were determined via the commercial ELISA kits. Results: Serum ZAG levels were the highest in the control group, then gradually decreased with the severity of the metabolic abnormalities increased (8.78 ± 1.66 μg/mL for control vs. 8.37 ± 1.52 μg/mL for central obesity vs. 7.98 ±
SUBMITTER: Wang L
PROVIDER: S-EPMC7105689 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA